PRIMOVIST sol inj 0.25 mmol/ml ser prê 10 ml
7680569360215
CH-56936
V08CA10
14.02.0.
1 / 3
google
Details
- Product number
- 5693601
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- dinatrii gadoxetas 181.43 mg, calcii trinatrii caloxetas, trometamolum, acidum hydrochloridum et natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 11.8 mg.
Articles (1)
Primovist 0.25 mmol/ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
181.43 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
11.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 188.70
Specialties list
Yes
Generic
No
SL addition date:
01/05/2006
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 56936
- Drug name
- Primovist 0.25 mmol/ml, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V08CA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/12/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 14.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PRIMOVIST sol inj 0.25 mmol/ml ser prê 10 ml
- Description (DE)
- PRIMOVIST Inj Lös 0.25 mmol/ml Fertspr 10 ml
- Market launch
- 10/12/2004
- Narcotic (BTM)
- No